Proteomics study the potential targets for Rifampicin-resistant spinal tuberculosis.
Wang Y, Yin S, Wang S, Rong K, Meng XH, Zhou H, Jiao L, Hou D, Jiang Z, He J, Mao Z.
Wang Y, et al. Among authors: meng xh.
Front Pharmacol. 2024 Apr 15;15:1370444. doi: 10.3389/fphar.2024.1370444. eCollection 2024.
Front Pharmacol. 2024.
PMID: 38694916
Free PMC article.